Articles

Prostate cancer is the most common nondermatologic cancer in males in the United States.1 Incidence and mortality rates vary significantly between countries. In the United States, the lifetime risk of developing prostate cancer is approximately 1 in 7, with an incidence similar to that of breast cancer. Read More ›

Until the late 1930s, stomach cancer-also called gastric cancer-was the leading cause of cancer death in the United States; although it is still a major cause of cancer-related deaths worldwide, it is now much less common in this country. Read More ›

Breast cancer is the leading cause of premature death in women. According to the American Cancer Society (ACS), more than 40,000 US women will die of breast cancer in 2015. Read More ›

CancerCare was started in 1944 with the mission of providing free professional support for people with cancer. The organization offers a spectrum of expanded services for cancer patients and their families and caregivers. Read More ›

In This Article

• Teamwork Improves Palliative Care and Saves Money
• Scan, Treat, and Repeat: Living with Long-Term Metastatic Disease
• APN-Led Clinic Improves Outcomes and Lowers Costs of Treating Head and Neck Cancer
• Coping with Body Image: An Ongoing Process for Patients and Providers

Read More ›

Welcome to our first newsletter in the Conquering the Multiple Myeloma Continuum series, which focuses on adherence to oral medications in patients with multiple myeloma (MM). In the first newsletter, you learned about some of the major causes of nonadherence that patients and their providers face; this second newsletter provides some strategies and solutions Read More ›

The past decade has witnessed dramatic progress in the treatment of multiple myeloma (MM), which has resulted in unprecedented improvements in survival outcomes. Read More ›

This peer-delivered program, brought to you by Takeda, will include a clinical overview of NINLARO and its product attributes. Read More ›

This peer-delivered program, brought to you by Takeda, will include a clinical overview of NINLARO and its product attributes. Read More ›

This peer-delivered program, brought to you by Takeda, will include a clinical overview of NINLARO and its product attributes. Read More ›